... FDA approved the regimen for prophylaxis against sexual transmission. Asked to comment, Paul Sax of Journal Watch HIV/AIDS Clinical Care said, "It's adherence to the regimen that will prove the most challenging in actual clinical practice." Reader ...
http://firstwatch.jwatch.org/cgi/content/short/2013/614/1?rss=1&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+PhysiciansFirstWatch+%28Physician%27s+First+Watch%3A+Current+Issue%29
http://firstwatch.jwatch.org/cgi/content/short/2013/614/1?rss=1&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+PhysiciansFirstWatch+%28Physician%27s+First+Watch%3A+Current+Issue%29
No comments:
Post a Comment